FDA Clears Emerging CT Device That Facilitates 50 Percent Reduction in CCTA Exam Time

News
Article

The Revolution Vibe computed tomography system reportedly facilitates quality low-dose imaging for cardiac exams in patients with arrhythmias, heavily calcified coronaries and stents.

The Food and Drug Administration (FDA) has granted 510(k) clearance for the Revolution Vibe computed tomography (CT) system, which reportedly enhances efficiency with coronary CT angiography (CCTA) exams.

Unveiled earlier this year at the American College of Cardiology (ACC) conference, the Revolution Vibe CT platform has an Effortless Workflow feature that reduces CCTA exam time by 50 percent, according to GE HealthCare, the manufacturer of the device.

FDA Clears Emerging CT Device That Facilitates 50 Percent Reduction in CCTA Exam Time

Unveiled earlier this year at the American College of Cardiology (ACC) conference, the Revolution Vibe CT system, which may enhance efficiency and imaging clarity with CCTA exams, recently garnered 510(k) clearance from the FDA. (Image courtesy of GE HealthCare.)

In addition to a variety of artificial intelligence (AI) tools to aid in automated protocol selection and easier patient positioning, GE HealthCare noted the Revolution Vibe CT system offers One-Beat Cardiac imaging, which provides efficient low-dose imaging clarity, even for patients that do not have an electrocardiogram (ECG) trace.

The company emphasized the capability of the Revolution Vibe CT system for improving CCTA assessments of patients with heavily calcified coronaries, arrhythmias and stents.

“Designed to help clinicians detect coronary artery disease and help plan valvular heart interventions quickly and confidently – even in complex cases – Revolution Vibe offers a practical, high-performance solution to help improve diagnostic accuracy, reduce exam time, and support better patient outcomes,” noted Jean-Luc Procaccini, the president and CEO of molecular imaging and computed tomography for GE HealthCare.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Diagnostic Imaging’s Top Five Breast Imaging Content: Summer 2025
Reducing Mammography Workload by Nearly 40 Percent? What a New Hybrid AI Study Reveals
Emerging Trends with Burnout in Radiology: An Interview with Chris Mattern, MD, Part 2
© 2025 MJH Life Sciences

All rights reserved.